Cardiawave SA, a deeptech medical device manufacturer that has developed Valvosoft®, an innovative non-invasive medical device to treat aortic stenosis, the most prevalent heart valve disease in adults, announces the issuance of 3 new patents in the United States.
LivaNova announces limited commercial release of Essenz Perfusion System for cardiopulmonary bypass procedures in select European centers. The system includes a next-gen heart-lung machine and a patient monitor that provides data-driven decisions during life-saving CPB procedures.
BD,a leading global medical technology company, had announced that it has received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic combination test for SARS-CoV-2, Influenza A + B and Respiratory Syncytial Virus (RSV) to help combat illness in the current and future respiratory virus seasons.
Preeclampsia Foundation Canada opens applications for 2023 Vision Grant program, announced at SMFM's.
BD, a leading medical tech company, announces a new high-throughput single-cell multiomics instrument that could speed up discovery across various fields, without sacrificing sample quality.
Aspivix announces Carevix™ cervical stabilizer gets FDA 510(k) clearance, offering millions of women in the US less painful gynecological procedures.
Olympus announced that it has been awarded a nationwide contract by Vizient Inc. for its smoke evacuation portfolio, including the OR-VAC™ Surgical Smoke Evacuator, Accessories and Tubing, Telescopic Smoke Pencil, Ultravision™ Generator and Accessories, and UHI-4 Insufflator. Effective February 1, 2023, the agreement offers Vizient members preferred pricing for these products.
Mikart, LLC –a comprehensive contract development and manufacturing organization the completion of a new liquids and suspensions suite in Atlanta, Georgia.
Medline a new partnership with Connecticut-based Integrated UVC Solutions to help healthcare providers enhance UV disinfection practices.
Datar Cancer Genetics Inc that the US Food and Drug Administration (FDA) has granted 'Breakthrough Device Designation' for its 'TriNetra™-Glio'.